Andrew Dudum is the CEO and co-founder of Hims & Hers Health, Inc., a company that provides accessible health and wellness products. With a background in entrepreneurship, he earned his Sociology degree from UCLA. Dudum leads a company that focuses...

Current Market Cap

$4.15B

Number of Employees

1.05K

Total Compensation

2020 - 2023

Trending up by 56.31% last year
Showing total compensation for the last 2020 - 2023

Stock

Up by 80.64% last year

Salary

Up by 4.17% last year

Bonus

Down by -4.58% last year

Other

Up by 5486.67% last year

Year

2023

Total Compensation

$8.48M

Salary

$625.00K

Board Justification

The compensation philosophy aims to attract and retain top talent while aligning executive compensation with company performance and shareholder interests through a mix of fixed and performance-based pay.

Bonus

$1.14M

Board Justification

The target annual incentive bonus opportunity for the CEO was set at 100% of his annual base salary, with actual bonuses based on achieving 183% of the target due to exceeding performance metrics for revenue and Adjusted EBITDA.

Other

$167.60K

Board Justification

This includes a $3,000 Company match for participation in the 401(k) Plan and reimbursement for a home security system.

Restricted Stock

$6.54M(567.14K RSU)

Board Justification

The RSU awards granted to the CEO vest quarterly over four years, with the first vesting date on June 15, 2023, subject to continuous service.

Performance Metrics

The performance metrics for determining the CEO's compensation included revenue and Adjusted EBITDA targets.

SEC Filing

From April 26, 2024

Andrew Dudum

Founder and CEO of Hims & Hers Health

H

Education

Bachelor's degree in Sociology from the University of California, Los Angeles

Field of Expertise

Business & Management - Entrepreneurship

Born

January 1, 1989 - 35 years ago

Is Founder?

Yes

Current Tenure

7 years 9 months (Jan 2017 - Present)

Previous Experience

Co-Founder of Hims & Hers Health, Inc.

View Holdings

Insider Holdings of Andrew Dudum

HIMS

$202.43M

$72.30M (55.55%)

Last Insider Trade

HIMS

$756.80K

HIMS at $16.54/share

Sep 20, 2024

Sale